Kevin Dolgin

Kevin Dolgin

Kevin Dolgin's picture
Kevin Dolgin has worked as a senior international consultant in marketing and strategy for the pharmaceutical industry for over 20 years. He is also an Associate Professor in management at Université de Paris I. Before Observia, he created the Areks, now part of IMS Health. He has an undergraduate degree from Fordham University, an MBA from INSEAD and a Master of Research from the Sorbonne. Observia is one of Europe’s foremost companies in the domain of adherence, focusing on digital health programs to improve patient outcomes. Observia’s mission is to help chronic patients adhere to the treatment given by their healthcare professional.

Latest posts from Kevin:


Digital: Teaching An Old Dog New...

Mar 20, 2017

Car maker Tesla has a few lessons for pharma on truly putting digital first


Are You Sponge Bathing Regularly?

May 27, 2016

Is pharma's money really where its mouth is when it comes patient support?


What Gets Measured Gets Done.

Mar 20, 2016

Do the KPIs on pharma's dashboard include adherence, a key indicator of...

Column, Commercial

Pharma's Patient Support:...

Jun 23, 2015

Why isn't pharma investing to increase patient support effectiveness?


Adherence Programs: What works?

Jan 8, 2015

What seperates successful adherence programs from unsuccessful ones?


The Patient Orientation Quiz

Nov 20, 2014

Hello all.It's been a few months since my last column, but I have a great...


Patient Adherence & The...

Jan 22, 2014

This month Kevin departs from the business end of patient support to examine an...


Measure for Measure

Oct 25, 2013

Kevin dismantles one of the biggest barriers to real investment in patient...


'Cause I Try and I Try and I...

Sep 17, 2013

This month Kevin explains why satisfaction is now pivotal to a successful...


I Can't Get No...

Aug 20, 2013

Kevin Dolgin explains one of the key measurable in a service-led industry,...